Hess Corporation Announces Notes Offering
Hess expects to use the net proceeds of the notes offering primarily for
the repurchase of its 8.125% Notes due 2019, its 7.875% Notes due 2029,
its 7.300% Notes due 2031 and its 7.125% Notes due 2033 that are
tendered pursuant to its cash tender offer announced earlier today and
to finance the redemption of its 1.300% Notes due 2017, as well as for
working capital and other general corporate purposes. The offering is
expected to close on
This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the prospectus supplement or the shelf registration statement or prospectus.
Copies of the prospectus meeting the requirements of Section 10 of the
Securities Act of 1933, as amended, may be obtained by contacting
Cautionary Statements
This news release contains statements about future events and
expectations, or “forward-looking statements,” all of which are
inherently uncertain. These forward-looking statements are based on
management’s current expectations and assumptions and not on historical
facts. Examples of these statements include, but are not limited to, our
ability to complete the offering and the expected timing for completion
and the anticipated use of proceeds from the offering. These
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results to differ materially from
those indicated in such forward-looking statements including prevailing
market conditions and other factors. For more information about
potential risk factors that could affect Hess and its results, we refer
you to the information contained in the prospectus and prospectus
supplement for the offering and the risk factors summarized in our Form
10-K for the year ended
Комментарии